Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Chimerix Inc shares valued at $12,000 were purchased by David Jakeman on Jan 30 ’25. At $4.00 per share, David Jakeman acquired 3,000 shares.
Also, Michael Andriole purchased 2,500 shares, netting a total of over 10,000 in proceeds.
Before that, Michelle LaSpaluto had added 1,100 shares to its account. In a trade valued at $4,400, the Officer bought Chimerix Inc shares for $4.00 each.
As published in their initiating research note from Robert W. Baird on May 23, 2023, Chimerix Inc [CMRX] has been an Outperform and the price target has been revised to $7. Analysts at CapitalOne started covering the stock with ‘”an Overweight”‘ outlook in a report released in early September. As of April 29, 2021, Maxim Group has initiated its “Buy” rating for CMRX.
Analyzing CMRX Stock Performance
During the last five days, there has been a surge of approximately 7.31%. Over the course of the year, Chimerix Inc shares have jumped approximately 18.10%. Shares of the company reached a 52-week high of $4.22 on 01/30/25 and a 52-week low of $3.12 on 01/13/25. A 50-day SMA is recorded $2.60, while a 200-day SMA reached $1.34. Nevertheless, trading volume fell to 1.35 million shares from 1.03 million shares the previous day.
Support And Resistance Levels for Chimerix Inc (CMRX)
According to the 24-hour chart, there is a support level at 4.03, which, if violated, would cause prices to drop to 3.94. In the upper region, resistance lies at 4.21. The next price resistance is at 4.30. RSI (Relative Strength Index) is 74.52 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.34, which suggests the price will decrease in the coming days. Percent R is at 10.00%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
